Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKakuzi Regulatory News (KAKU)

Share Price Information for Kakuzi (KAKU)

Share Price is delayed by 15 minutes
Get Live Data
92.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £18.13m
KAKU Live PriceLast checked at - London Stock Exchange

Intraday Kakuzi Share Chart

Half Yearly Report

27 Aug 2014 07:00

RNS Number : 0534Q
Kakuzi Ld
27 August 2014
 



KAKUZI LIMITED

 

EXTRACT FROM THE INTERIM FINANCIAL STATEMENTS

FOR THE PERIOD OF SIX MONTHS TO 30 JUNE 2014

 

The unaudited results for the Kakuzi Group for the period of six months to 30 June 2014 and the comparative figures for the previous year are as follows:

 

Condensed Consolidated Statement of Comprehensive Income

30 June 2014

30 June 2013

Shs'000

Shs'000

Sales

447,623

428,988

Profit before fair value gain in Biological assets and income tax

57,732

91,857

Fair value gain in Biological assets

18,506

21,015

Profit before income tax

76,238

112,872

Income tax expense

(27,282

)

(35,700

)

Profit for the period

48,956

77,172

Other Comprehensive Income

-

-

Total comprehensive income

48,956

77,172

Total comprehensive income attributable to

Equity holders of the company:

48,956

77,172

Shs

Shs

Earnings per share attributable to equity holders of the company:

Basic and diluted earnings per stock unit

2.50

3.94

Condensed Consolidated Statement of Financial Position

Audited

30 June 2014

30 June 2013

31 December 2013

Shs'000

Shs'000

Shs'000

EQUITY

Share capital

98,000

98,000

98,000

Other reserves

9,986

(1,289

)

9,986

Retained earnings

2,771,498

2,708,186

2,722,542

Proposed dividends

-

-

73,500

Total equity

2,879,484

2,804,897

2,904,028

Non-current liabilities

684,697

648,843

666,334

3,564,181

3,453,740

3,570,362

REPRESENTED BY

Non-current assets

2,630,233

2,422,813

2,546,888

Current assets

350,214

349,114

265,897

Cash and cash equivalents

793,019

859,697

904,758

Current liabilities

(209,285

)

(177,884

)

(147,181

)

Net current assets

933,948

1,030,927

1,023,474

3,564,181

3,453,740

3,570,362

 

Overview:

 

The above is an extract from the interim financial statements which have been prepared in accordance with the International Financial Reporting Standards (IFRS).

 

The major cause of the reduced profits has been mainly due to the lower tea prices in the first half of the year and the increased cost charges to revenue on Macadamia as early planted fields come to maturity.

 

 

Our Balance Sheet remains strong and under present conditions we would look towards similar profit levels to last year but as is often stated by your Directors, forecasting in a commercial agriculture environment is difficult.

 

 

The Directors do not recommend the payment of an Interim Dividend.

 

 

BY ORDER OF THE BOARD

 

K W Tarplee

Chairman

26 August 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR PGUUURUPCGQQ
12
Date   Source Headline
25th Mar 20267:00 amRNSAnnual Financial Report
19th Nov 20257:00 amRNSCAUTIONARY ANNOUNCEMENT
20th Aug 20257:00 amRNSHalf-year Report
25th Mar 20257:00 amRNS2024 Final Results Announcement
27th Nov 20246:30 pmRNSProfit Warning Announcement
21st Aug 20247:00 amRNSHalf-year Report
20th Mar 20248:27 amRNSAnnual Financial Report
6th Dec 20237:00 amRNSProfit Warning Announcement
25th Aug 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSDirectorate Change
22nd Mar 20237:00 amRNSAnnual Financial Report
19th Aug 20227:00 amRNSHalf-year Report
23rd Mar 20227:00 amRNSAnnual Financial Report
6th Jan 20227:00 amRNS2021 PROFIT WARNING ANNOUNCEMENT
18th Aug 20217:00 amRNSHalf-year Report
22nd Mar 20217:00 amRNSAnnual Financial Report - Replacement
19th Mar 20217:00 amRNSAnnual Financial Report
2nd Nov 20207:00 amRNSDirectorate Change
19th Aug 20207:00 amRNSHalf-year Report
26th May 20207:00 amRNSAGM Statement
9th Apr 20207:00 amRNSDividend Declaration
20th Mar 20207:00 amRNSAnnual Financial Report
19th Feb 20207:00 amRNSDeath Of Director
15th Aug 20197:00 amRNSHalf-year Report
29th Mar 20197:00 amRNSAnnual Financial Report
15th Aug 20187:00 amRNSHalf-year Report
23rd Mar 20187:00 amRNSAnnual Financial Report
7th Aug 20177:00 amRNSHalf-year Report
29th Mar 20177:00 amRNSDirectorate Change
29th Mar 20177:00 amRNSAnnual Financial Report
3rd Aug 20167:00 amRNSDirectorate Change
3rd Aug 20167:00 amRNSHalf-year Report
17th Mar 20167:00 amRNSAnnual Financial Report
12th Aug 20157:00 amRNSHalf Yearly Report
27th May 20157:00 amRNSDirectorate Change
25th Mar 20157:00 amRNSAnnual Financial Report
27th Aug 20147:00 amRNSHalf Yearly Report
19th Mar 20147:00 amRNSFinal Results
27th Nov 20137:00 amRNSPROFIT WARNING
27th Aug 20137:00 amRNSHalf Yearly Report
2nd Apr 20137:00 amRNSDirectorate Change
2nd Apr 20137:00 amRNSAnnual Financial Report
30th Nov 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSProfit Warning Announcement
31st Aug 20127:00 amRNSInterim Financial Statements
22nd Aug 20127:00 amRNSDisposal
2nd Apr 20127:00 amRNSFinal results for the year ended 31 Dec 2011
7th Feb 20127:00 amRNSPublic Announcement
30th Aug 20117:11 amRNSHalf Yearly Report
18th Mar 20118:03 amRNSFinal Results 2010 Replacement
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.